Literature DB >> 2438992

Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology.

L Edvinsson, R Ekman, I Jansen, A Ottosson, R Uddman.   

Abstract

Nerve fibers containing neuropeptide Y, vasoactive intestinal peptide (VIP), substance P (SP), and calcitonin gene-related peptide (CGRP) were seen in the adventitia or at the adventitia-media border of human cerebral arteries obtained during neurosurgical procedures. Radioimmunoassay of human cerebral arteries, removed at autopsy, revealed that the levels of the four peptides did not differ among the major cerebral arteries. There was, however, a gradual decline in peptide concentrations with increasing age of the patients, as measured in the proximal part of the middle cerebral artery. Pharmacological experiments on fresh segments of cerebral (pial) arteries in vitro revealed that neuropeptide Y caused vasoconstriction per se but did not potentiate the contractile response of noradrenaline. VIP, peptide histidine methionine-27 (PHM-27), SP, neurokinin A (NKA), and human CGRP potently relaxed vessels precontracted by prostaglandin F2 alpha, the relative potency being human CGRP greater than SP greater than VIP greater than NKA greater than PHM-27. The amount of relaxation varied between 55% (SP) and 96% (human CGRP) of the prostaglandin F2 alpha-induced contraction. The peptide effects were not antagonized by propranolol, atropine, or cimetidine, suggesting an action that does not involve adrenergic, cholinergic, or histaminergic receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438992     DOI: 10.1002/ana.410210503

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

1.  Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.

Authors:  R Juul; L Edvinsson; T A Fredriksen; R Ekman; A O Brubakk; S E Gisvold
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  Cerebrovascular responses to capsaicin in vitro and in situ.

Authors:  L Edvinsson; I Jansen; T A Kingman; J McCulloch
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

3.  Influence of perivascular peptides on endoneurial blood flow and microvascular resistance in the sciatic nerve of the rat.

Authors:  D W Zochodne; L T Ho
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

4.  Nerve growth factor concentrations in human cerebral blood vessels.

Authors:  P Anand; A Parrett; L Chadwick; P Hamlyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

Review 5.  CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?

Authors:  C S Walker; D L Hay
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?

Authors:  Eva V L Roloff; Ana M Tomiak-Baquero; Sergey Kasparov; Julian F R Paton
Journal:  J Physiol       Date:  2016-10-05       Impact factor: 5.182

Review 7.  Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

Authors:  L Edvinsson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  Endogenous methyl palmitate modulates nicotinic receptor-mediated transmission in the superior cervical ganglion.

Authors:  Hung Wen Lin; Chao-Zong Liu; Deshou Cao; Po-Yi Chen; Mei-Fang Chen; Shinn-Zong Lin; Mansoor Mozayan; Alex F Chen; Louis S Premkumar; Donald S Torry; Tony J-F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

Review 9.  Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.

Authors:  Håkan Ashina; Lawrence Newman; Sait Ashina
Journal:  Neurol Sci       Date:  2017-08-30       Impact factor: 3.307

10.  Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers.

Authors:  Jakob Møller Hansen; Jesper Petersen; Troels Wienecke; Karsten Skovgaard Olsen; Lars Thorbjørn Jensen; Messoud Ashina
Journal:  J Headache Pain       Date:  2009-03-06       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.